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Impaired haematopoietic stem cell differentiation and
enhanced skewing towards myeloid progenitors in
aged caspase-2-deficient mice
Swati Dawar1, Nur Hezrin Shahrin1, Nikolina Sladojevic1, Richard J D’Andrea1, Loretta Dorstyn1,3, Devendra K Hiwase1,2,3 and
Sharad Kumar*,1,3
The apoptotic cysteine protease caspase-2 has been shown to suppress tumourigenesis in mice and its reduced expression
correlates with poor prognosis in some human malignancies. Caspase-2-deficient mice develop normally but show ageing-related
traits and, when challenged by oncogenic stimuli or certain stress, show enhanced tumour development, often accompanied by
extensive aneuploidy. As stem cells are susceptible to acquiring age-related functional defects because of their self-renewal and
proliferative capacity, we examined whether loss of caspase-2 promotes such defects with age. Using young and aged Casp2−/−
mice, we demonstrate that deficiency of caspase-2 results in enhanced aneuploidy and DNA damage in bone marrow (BM) cells
with ageing. Furthermore, we demonstrate for the first time that caspase-2 loss results in significant increase in
immunophenotypically defined short-term haematopoietic stem cells (HSCs) and multipotent progenitors fractions in BM with
a skewed differentiation towards myeloid progenitors with ageing. Caspase-2 deficiency leads to enhanced granulocyte
macrophage and erythroid progenitors in aged mice. Colony-forming assays and long-term culture-initiating assay further
recapitulated these results. Our results provide the first evidence of caspase-2 in regulating HSC and progenitor differentiation, as
well as aneuploidy, in vivo.
Cell Death and Disease (2016) 7, e2509; doi:10.1038/cddis.2016.406; published online 1 December 2016
Caspase-2, a CARD-containing caspase, is the most
evolutionarily conserved member of the caspase family.1–3 In
addition to its function in cell death, it has been shown to act as
a tumour suppressor (reviewed in Puccini et al.4). For
instance, CASP2 on human Ch7q is frequently deleted in
haematological malignancies5 and reduced CASP2 expres-
sion is noted in Burkitt’s lymphoma, mantle cell lymphoma,
chronic lymphocytic leukaemia (CLL) and hairy cell leukae-
mia, and correlates with poor prognosis in acute myeloid
leukaemia (AML) and acute lymphocytic leukemia (ALL).6–8 In
The Cancer Genome Atlas (TCGA) (http://cancergenome.nih.
gov/) and BloodSpot databases, lower CASP2 expression is
clearly linked to poor patient survival in AML (http://servers.binf.
ku.dk/bloodspot/?gene=CASP2&dataset=normal_human_v2_
with_AMLs).
The correlative observations indicating a role for caspase-2
in human malignancies are supported by experimental
evidence in mouse models of tumours. For example,
caspase-2 deficiency enhances lymphomagenesis in
Eμ-Myc transgenic mice that develop B-cell lymphoma9,10
and in ataxia telangiectasia mutated (Atm)-deficient mice that
spontaneusly develop thymic lymphoma.11 Furthermore,
MMTV/c-neu-driven mammary carcinoma,12 K-Ras-driven
lung carcinoma13 and diethylnitrosamine-mediated hepato-
cellular carcinoma14 also show more rapid develoment of
tumours in caspase-2-deficient (Casp2−/−) mice. In addition,
in vitro studies demonstrate that mouse embryonic flibroblasts
(MEFs) derived from Casp2−/− mice become immortalized
more readily and show enhanced sensitivity to transformation
by oncogenes, including Ras and cMyc.9,15 Interestingly
though, not all types of tumours are affected by the loss of
caspase-2,10,16 suggesting that the nature of cell types
involved (such as their proliferative capacity) may determine
the participation of caspase-2 as a tumour suppressor. One
commonly observed feature of caspase-2-deficient tumours
and MEFs is enhanced aneuploidy,4,11,12,14,15,17 likely
because of reduced or inefficient apoptotic removal of aberrant
cells in the absence of caspase-2.
In addition to enhanced sensitivity to tumourigenesis,
Casp2−/− mice show signs of premature ageing including
increased oxidative stress and DNA damage.18,19 Our
previous work suggests that the ageing phenotype is partly
because of increased oxidative stress-induced damage and
impaired antioxidant response.18,20 In oxidative challenge
experiments we observed increased tissue damage, accom-
panied by higher serum IL-6 and IL-1β levels inCasp2−/−mice
compared with wild-type (WT) animals.14,20 More recent
studies suggest a role for caspase-2 in the regulation of age-
related proteostasis, energy metabolism, lipid metabolism and
sex-specific alterations in glucose homeostasis.21,22 As loss of
caspase-2 increases genomic instability and predisposes
mice to various types of tumours we hypothesize that
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caspase-2 deficiency results in a compromised state that is
more susceptible to various oxidative and oncogenic insults,
including that associated with ageing.
Stem cells are highly susceptible to acquiring age-related
phenotypic and functional changes, such as aneuploidy, DNA
damage and skewed differentiation potential, owing to their
high self-renewal and regenerative capacities.23,24 Therefore,
this study examined whether caspase-2 deficiency could
exacerbate these age-related changes in the haematopoietic
stem cell (HSC) and haematopoietic stem and progenitor cell
(HSPC) lineages in the bone marrow (BM). Our data suggest
that aged Casp2−/− mice indeed show significant impairment
of HSC differentiation and enhanced skewing towards myeloid
progenitors compared with WT mice. Furthermore, our data
also suggest that caspase-2 deficiency alone is sufficient for
increased number of aneuploid cells in the BM of aged
animals.
Results
The CASP2 data in BloodSpot suggest high-level expression
in the myeloid lineage including common myeloid precursor
cells, granulocyte monocyte progenitors, early and late
promyelocytes, myelocytes and megakaryocyte erythoid
Figure 1 Functional characterization of HSPCs in Casp2−/− mice. (a) HSPC and myeloid progenitor cells from Lin−, IL7Rα− bone marrow cells quantitated by flow
cytometry. Results were obtained from WT (n= 6) and Casp2−/− (n= 8) mice at 24 months. Data represented as mean±S.E.M., **Po0.01. (b) The percentage of total HSPC
cells from c-Kit+, IL7Rα−, Sca-1+ population in the bone marrow from 24-month-old mice followed by (c) ST-HSC and (d) MPP. Results were obtained from WT (n= 6) and
Casp2−/− (n= 8) mice at 24 months. Data represented as mean± S.E.M. P-values are indicated as either non-significant (ns) or *Po0.05. (e) LTC-IC assay. Representative
image of colonies obtained from 5 weeks of culture of BM cells from WTand Casp2−/− mice. Scale bar= 50 μM. (f) Quantitation of colonies obtained from LTC-IC assay for WT
(n= 4) and Casp2−/− (n= 4) mice at 24 months. Data represented as mean± S.E.M. *Po0.05
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progenitor cells. This observation, combined with a putative
role for caspase-2 in haematopoietic tumours, suggested that
caspase-2 function may be of particular significance in the
haematopoietic lineage.
To test the impact of caspase-2 loss in haematopoiesis with
ageing, primary BM cells were isolated from young
(4–6 weeks) and aged (18–24 months) Casp2−/− mice25 and
assessed for HSPC fractions by flow cytometry26,27 and for
long-term culture-initiating cell (LTC-IC), BM-derived colony-
forming unit granulocyte–macrophage (CFU-GM) and serial
replating assays. Though total bone marrow morphology was
not substantially different between aged WT and Casp2−/−
mice (Supplementary Figure S1), BM cells from aged
Casp2−/− mice had significantly higher HSPC and myeloid
progenitors (defined by Lin−, ILR7α−) compared with agedWT
mice (Figure 1a and b). Similarly, short-term HSC (ST-HSC)
(defined by Lin−, c-Kit+, ILR7α−, Sca-1+, CD48+, and CD150+)
and mutipotent progenitor (MPP) (defined by Lin−, c-Kit+,
ILR7α−, Sca-1+, CD48+, CD150−) fractions were significantly
higher in aged Casp2−/− BM cells compared with the aged
WT BM cells (Figure 1c and d). In contrast, there were no
differences in these BM cell fractions in young WT com-
pared with young Casp2−/−mice (Figure 2a–d). These results
were further substantiated by LTC-IC and serial replating
assays to assess HSPC self-renewal and differentiation
capacity.
Assay of total BM from agedCasp-2−/−mice was consistent
with increased LTC-IC compared with aged WT BM cells
(Figure 1e and f). Similarly, serial replating assays of BM
mononuclear cells demonstrated a significant increase in
burst-forming unit erythroid cells (BFU-E) at first plating for
aged Casp2−/− compared with aged WT BM cells. In contrast,
CFU-GM and CFU granulocyte, erythrocyte, macrophage
and megakaryocyte (CFU-GEMM) frequency did not differ at
first plating, but thesemyeloid progenitors displayed increased
replating frequency upon secondary and tertiary plating
(Figure 3d–f). Colony numbers from primary, secondary or
tertiary plating of BM cells from young WT compared with
young Casp2−/− cells were not different (Figure 4c–e).
These results are consistent with caspase-2 deficiency
resulting in expansion and enhanced self-renewal of the
primitive HSC and myeloid progenitor compartment
with ageing.
Figure 2 Functional characterization of HSPC in young Casp2−/− mice. (a) The percentage of total HSPC and myeloid progenitor cells (Lin−, IL7Rα−) from BM using flow
cytometry. Results were obtained from young WT (n= 5) and young Casp2−/− (n= 6) mice. Data represented as mean± S.E.M. P-values were non-significant (ns). (b) The
percentage of total HSPCs from c-Kit+, Lin− population in the BM of young mice followed by (c) ST-HSC and (d) MPP. Results were obtained from young WT (n= 5) and young
Casp2−/− (n= 6) mice. Data represented as mean±S.E.M. P-values are ns
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HSCs are highly susceptible to acquiring precancerous
damage such as aneuploidy, DNA damage and skewed
differentiation because of their self-renewal and differentiation
capacity.24 The acquisition of such damage increases with
ageing in murine and human bone marrow,28 most probably
because of their enhanced self-renewal capacity, even though
the regenerative capacity of individual stem cells is reduced
under stress (i.e., serial transplantation) compared with young
HSCs.29,30 Normally, the danger caused by mutagenic
accumulation in ageing HSC is prevented by the activity of
tumour suppressor proteins that sense potentially malignant
clones and trigger apoptosis or growth arrest.29 It is therefore
Figure 3 Characterization of myeloid progenitor cells in Casp2−/− mice. (a) The myeloid progenitor cells from ckit+, sca1−, Lin−, IL7Rα− from bone marrow quantitated by
flow cytometry. Results were obtained from WT (n= 7) and Casp2−/− (n= 8) mice at 24 months. Data represented as mean± S.E.M. P-values are indicated with *Po0.05.
(b) The percentage of GMP and (c) CFU-E in the bone marrow using flow cytometry. Results were obtained from WT (n= 6) and Casp2−/− (n= 7) mice at 24 months.
Data represented as mean±S.E.M. P-values are indicated as either non-significant (ns) or **Po0.01. (d) Quantitation of myelo-erythroid progenitor self-renewal from aged
bone marrow cells (24 months) using serial colony-forming assay. Colonies scored for CFU-GM obtained from WT (n= 5) and Casp2−/−(n= 6) mice. Data represented
as mean±S.E.M. P-values are indicated as either ns or *Po0.05. (e and f) Colonies scored for CFU-BFU-E (e) and CFU-GEMM (f) obtained from WT (n= 5) and
Casp2−/−(n= 6) mice. Data represented as mean±S.E.M. P-values are indicated as either ns or *Po0.05. The symbol ‘ω’ denotes that no colonies were formed
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plausible that caspase-2 may have an important cell death
function in HSCs to prevent survival of potential mutagenized
cells to prevent onset of haematopoietic malignancies.
Though aged Casp2−/− mice show apparently normal total
blood counts, and do not develop spontaneous age-related
tumours,18 caspase-2-deficiency strongly enhances tumour
development in various mouse models.9–14 This indicates that
loss of caspase-2 on its own may not be sufficient to induce
tumourigenesis, but increases tumour susceptibility in
response to cellular stress (i.e. replicative or oncogenic
stress). A recent clinical study established that clonal
haematopoiesis, with somatic mutations in genes involved in
myeloid malignancies, is increasingly common as people
age.31 Importantly, these individuals harbouring somatic
mutations in myeloid genes had normal blood counts at the
time of mutation testing, but had increased risk of
Figure 4 Characterization of myeloid progenitor cells in young Casp2−/− mice. The percentage of (a) GMP and (b) CFU-E in the BM quantitated by flow cytometry. Results
were obtained from WT (n= 5) and Casp2−/−(n= 6) mice. Data represented as mean± S.E.M. P-values are indicated as non-significant (ns). (c–e) Quantitation of myelo-
erythroid progenitor self-renewal from BM using serial colony-forming assay. Colonies scored for CFU-GM (c), CFU-BFU-E (d) and CFU-GEMM (e) obtained fromWT (n= 5) and
Casp2−/−(n= 6) mice. Data represented as mean± S.E.M. P-values are indicated as ns. The symbol ‘ω’ denotes that no colonies were formed
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haematological malignancies during follow-up. Most haema-
tological malignancies arise only after the acquisition of
multiple mutagenic events, and the incidence of these
haematological malignancies increase with ageing. Gene
expression data indicate that CASP2 expression is also lower
in AML stem cells compared with normal HSCs, and within an
AML cohort, low CASP2 expression is associated with poor
outcome of AML cases (NCI-Cancer Genome Atlas and
BloodSpot databases). In addition, CASP2 expression is
higher in normal human HSCPs compared with mature
monocytes and granulocytes (BloodSpot database), probably
essential to eliminate damaged HSCPs.
As the ageing haematopoietic system is associated with
expansion of myeloid progenitors,29 we assessed the impact
of caspase-2 deficiency on these progenitors in aged mice.
Analysis of the BM myeloid lineage, including myeloid pro-
genitors (MPs) (defined by Lin−, c-Kit+, ILR7α−, and Sca-1−),
granulocyte macrophage progenitors (GMPs) (defined by
Lin−, c-Kit+, Sca-1−, CD41−, CD16/32+, and CD 150−), mega-
karyocyte erythrocyte progenitors (MEPs) (defined by c-Kit+,
Lin−, Sca-1−, CD41−, CD16/32−, CD105−, and CD150+),
megakaryocyte progenitors (MkPs) (defined by c-Kit+, Lin−,
Sca-1−, CD41+, and CD150+) and erythroid progenitors
(CFU-E) (defined by Lin−, c-Kit+, Sca-1−, CD41−, CD16/32−,
CD105+, and CD150−), was performed in both young and
aged mice. Aged Casp2−/− BM cells exhibited significantly
increased frequency of myeloid progenitors with a trend
towards enhanced GMP populations (Figure 3a and b)
compared with aged WT BM cells. Aged Casp2−/− BM cells
also showed a trend of higher erythroid progenitor populations
(Figure 3c) compared with aged WT BM cells. Intriguingly, no
differenceswere seen in these progenitor cell populations from
young WT and Casp2−/− mice (Figure 4a and b). This result,
combined with the clonal assays in Figure 3d–f, suggest that
loss of caspase-2 results in a skewing of haematopoiesis
towards the myeloid lineage with ageing. These results are
consistent with a study demonstrating age-related skewing
towards myelopoiesis in adult human BM and further indicate
that loss of caspase-2 enhances this phenotype.30
As stem cells are susceptible to acquiring mitotic defects
with age because of their self-renewal capacity,23,24 we
examined whether loss of caspase-2 exacerbates age-
related aneuploidy in BM. Indeed, aged Casp2−/− mice, but
not young mice, exhibited significantly enhanced aneuploidy
Figure 5 Caspase-2 deficiency enhances aneuploidy and DNA damage in primary BM cells with ageing. (a) Representative fluorescent images (magnification of 100 ×) of
DAPI-stained metaphase spreads, with chromosome counts indicated, from aged WT (n= 4) and aged Casp2−/− (n= 4) BM cells. (b) Quantitation of metaphases showing
frequencies of diploid and aneuploid karyotypes in BM cells from aged WT (n= 4) and Casp2−/− (n= 4) mice. A total of 50 metaphase spreads were counted per mouse. Data
represented as mean± S.E.M. and *Po0.05, χ2 test. (c) Table indicating actual chromosome numbers from aged WTand aged Casp2−/− BM cells showing reduced cells with
diploid number of chromosomes indicated (shaded) and increased aneuploidy in Casp2−/− BM cells. (d) Representative fluorescent images (magnification of 63 × ) of phospho-
histone H2AX (Ser139)-stained BM cells from aged WT (n= 4) and aged Casp2−/− (n= 4) mice. Arrows highlight cells with multiple γH2AX foci. Scale bar= 10 μM.
(e) Quantitation of phospho-histone H2AX-positive nuclei of BM cells from aged WT (n= 4) and Casp2−/− (n= 4) mice. Data represented as mean± S.E.M. and *Po0.05
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in BM compared with WT mice (Figures 5a–c and 6a–c).
These results indicate that Casp2−/− BM cells are more
susceptible to aneuploidy in vivo with ageing and also may
explain the association of reduced caspase-2 expression with
poor survival in AML, as aneuploidy is a negative prognostic
indicator.32,33 As ageing is associated with accumulation of
DNA damage in HSC,24,34 we assessed this and observed
significantly enhanced basal γH2AX foci together with an
increased number of γH2AX-positive cells in aged Casp2−/−
BM compared with agedWT cells (Figure 5d and e). Together,
these results suggest that caspase-2 deficiency enhances
aneuploidy associated with increased DNA damage in BM
with ageing.
Discussion
Caspase-2 deficiency has previously been linked to enhanced
haematopoietic malignancy in both humans and mouse
models. In this work we now demonstrate a previously
unrecognized role for caspase-2 in maintaining HSC home-
ostasis with ageing that may play a role in premature ageing
and enhanced susceptibility to tumourigenesis associated
with Casp2−/− animals. We also show for the first time that
caspase-2 loss alone is sufficient for accumulation of
aneuploid cells in the BM with age. Our previous work has
shown that caspase-2-deficient tumours, as well as MEFs,
have increased tendency to become aneuploid and has
suggested that this could be because of reduced cell death
in a caspase-2-deficient background.11,15 Our recent work
with live cell imaging of mouse splenocytes ex vivo has
demonstrated that caspase-2 is required for deleting mitoti-
cally aberrant cells, including aneuploid cells, and that the
absence of caspase-2 can promote the long-term survival of
such aberrant cells.34 Thus, the accumulation of aneuploid
cells in the BM ofCasp2−/− animals with age is consistent with
the idea that caspase-2-dependent cell death limits aneu-
ploidy, given BM is the compartment where there is continuous
cell division, thus increasing the likelihood of these cells
having mitotic aberrations.
In the BM, one of the consequences of ageing is that blood
cell composition becomes skewed toward myeloid cells, with
increased incidence of myelogenous cancer, whereas the
main forms of acute leukemia in children is of the lymphoid
lineages.28–31 Our previous studies have demonstrated that
aged Casp2−/− mice exhibit increased reactive oxygen
species (ROS) and reduced stress tolerance that is asso-
ciated with increased DNA damage.15,18,20 ROS-related DNA
damage is a well-established factor known to compromise
HSC renewal and differentiation capacity with ageing.35 A
robust oxidative stress response, together with accurate repair
of DNA damage, are critical for HSC maintenance and
protection against functional decline of HSCs during
ageing.29,35 The BM compartment comprises a low-oxygenic
niche to ensure protection from ROS-induced stress and
damage and this protection is lost during the ageing
process.36 ROS is also known to play a critical role in lineage
decision of myeloid progenitors and can promote differentia-
tion into GMP.37 Therefore, it is possible that the increased
ROS in Casp2−/− mice contributes to the observed age-
related DNA damage and aneuploidy, as well as the enhanced
myeloid skewing with age.
As the precise mechanisms underlying haematopoietic
ageing remain poorly understood, the Casp2−/− mice may
provide a useful tool to further develop this hypothesis.
Additional studies will be important to determine the molecular
pathway by which caspase-2 regulates HSC and progenitor
genomic stability and differentiation, and to assess any
increase in susceptibility of agedCasp2−/−mice to leukaemia.
Such knowledge will provide insight into the causative factors
associated with increased incidence of haematological
malignancies with ageing.
Materials and Methods
Mice. Caspase-2 knockout (Casp2−/−) mice have been described previously.18,25
These mice have been backcrossed to a C57BL/6 background for at least 20
generations. Animals were maintained in specific pathogen-free conditions in a
12 h/12 h light/dark cycle and all animal breeding and studies were approved by the
SA Pathology/Central Northern Adelaide Health Services Animal Ethics Committee.
Flow cytometry analysis. BM cells were stained and analysed according to
previously described protocols.26,27 For the stem cell and lymphoid progenitor
panel, 8 × 105 of BM cells were stained with the following antibodies: FITC anti-
mouse CD48 (BioLegend, San Diego, CA, USA), Anti-mouse CD135 (Flt3)
(eBioscience, San Diego, CA, USA), APC anti-mouse CD150 (SLAM) (BioLegend),
Anti-mouse CD117 (c-Kit) APC-eFluor (eBioscience), Pacific Blue anti-mouse Ly-
6A/E (Sca-1) (BioLegend), Biotin anti-mouse CD127 (IL-7Rα) (BioLegend),
StrepAvidin-PECy7 (BioLegend) and lineage antibodies (CD3e-PECy5
(eBioscience), B220-PECy5 (BioLegend), Gr1-PECy5 (BioLegend), Mac1-PECy5
Figure 6 Caspase-2 deficiency does not enhance aneuploidy in primary BM cells
from young mice. (a) Representative fluorescent images (magnification of 100 ×) of
DAPI-stained metaphase spreads, with chromosome counts indicated, from young
WT (n= 4) and young Casp2−/− (n= 4) BM cells. (b) Quantitation of metaphases
showing frequencies of diploid and aneuploid karyotypes in BM cells from young WT
(n= 4) and young Casp2−/− (n= 4) mice. A total of 50 metaphase spreads were
counted per mouse. P-value is indicated as non-significant (ns). (c) Table indicating
actual chromosome numbers from young WTand young Casp2−/− BM cells showing
no difference in diploid number of chromosomes (shaded)
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(BioLegend) and TER-119-PECy5 (BioLegend)). The gating strategy for stem and
lymphoid progenitor cell analysis is shown in Supplementary Figure S2.
For the myeloid progenitor panel, 8 × 105 BM cells were stained with the following
antibodies: FITC rat anti-mouse CD41 (BD Pharmingen, San Jose, CA, USA), PE rat
anti-mouse CD16/32 (BD Pharmingen), APC anti-mouse CD150 (SLAM)
(BioLegend), Anti-mouse CD117 (c-Kit) APC-eFluor (eBioscience), Pacific Blue
anti-mouse Ly-6A/E (Sca-1) (BioLegend), PE/Cy7 anti-mouse CD105 (BioLegend)
and lineage antibodies (PE/Cy5 anti-mouse CD3ɛ (eBioscience), PE/Cy5 anti-mouse
CD11b (BioLegend), PE/Cy5 anti-mouse CD45R/B220 (BioLegend), PE/Cy5 anti-
mouse Ly-6G/Ly-6C (Gr-1) (BioLegend) and PE/Cy5 anti-mouse TER-119
(BioLegend)). Samples were run on Fortressa Flow Cytometer (BD Biosciences,
San Jose, CA, USA) and data analysis was performed using FCS Express Flow
Cytometry Research Edition Version 4 (DeNovo Software, Glendale, CA, USA). The
gating strategy for myeloid progenitor cell analysis is shown in Supplementary
Figure S3.
CFU assay. Methylcellulose colony-forming assays were performed using
MethoCult GF M3434 (Stem Cell Technologies, Vancouver, BC, Canada) according
to the manufacturer’s protocol.38 Briefly, 1 × 104 BM cells were seeded in triplicate.
CFU-GM and spontaneous BFU-E colonies,450 cells in size, were counted at day
7 post seeding. Representative photographs for colony morphology were taken
using an Olympus CK2 microscope (Olympus Corporation, Japan, Tokyo) and DP11
camera system at a magnification of 100 ×. For serial replating assays, cells from
the triplicate day 7 post seeding were harvested and washed 3 times in IMDM
media to wash away the MethoCult. Again, 1 × 104 BM cells were seeded in
triplicate. At day 7 post seeding, colonies were scored and the same procedures
were repeated.
LTC-IC assay. LTC-IC assay was carried out as described previously.39 BM
cells were plated in duplicate on AFT024 feeder cell layers (irradiated with 20 Gy)
established in 24-well plates in MyeloCult M5300 (Stem Cell Technologies) freshly
supplemented with 10− 6 M hydrocortisone. Cultures were maintained for 5 weeks
at 37 °C with weekly half-media changes before seeding the harvested cells for
CFU assays. Representative colony images were taken using a stereomicroscope
(Nikon, Tokyo, Japan).
Cytogenetic and DNA damage analysis. Preparation of chromosome
spreads and DNA damage analysis was carried out as previously described.11,15
Chromosome spreads were prepared by adding colcemid (20 ng/ml) 4 h before
harvesting cells by trypsinization, hypotonic treatment (0.075 M KCl) and fixation in
fresh ice-cold Carnoy’s fixative (methanol/glacial acetic acid at 3 : 1) for 10 min at
37 °C. Cells were centrifuged at 1000 r.p.m., washed three times in Carnoy’s fixative
and dropped onto wet glass slides, air dried and then placed in a 60 °C oven
overnight. Cells were stained with DAPI and chromosomes quantitated by
epifluorescence microscopy (model BX51; Olympus) and camera (UCMAD3/
CVM300, Olympus). Cells were visualized under 40 × or 100 × ULAPO objective
lens with NA= 1.5. Images were processed using Olysia BioReport Software
(Olympus) and manually merged using Adobe Photoshop 6.0 software (Adobe
Systems Inc., San Jose, CA, USA).
For DNA damage analysis, primary BM cells (1 × 105) were fixed in 4% w/v
paraformaldehyde for 15 min at 4 °C, permeabilized with 0.25% v/v Triton X-100/PBS
for 10 min at RT and then blocked in 1% w/v BSA/PBS for 1 h at RT. Cells were
incubated with anti-phospho-histone H2AX (Ser139) primary antibody (Cell Signaling
Technology, Danvers, MA, USA) diluted in blocking buffer, overnight at 4 °C. Following
3 washes in blocking buffer, cells were incubated with donkey anti-rabbit Alexa Fluor
488 secondary antibody (Life Technologies, Carlsbad, CA, USA) diluted 1 : 1000 in
blocking buffer for 1 h at RT. Following antibody incubations and washes in PBS, cells
were counterstained with 2 μg/ml DAPI for 5 min and mounted with ProLong Gold
Antifade Reagent (Thermo Fisher Scientific, Waltham, MA, USA). At least 100 cells
were scored for each sample. Fluorescent images were captured using a LSM 800
confocal laser scanning microscope (Zeiss, Oberkochen, Germany).
Giemsa staining. BM cell cytospins were stained using Aerospray Hematology
Pro (EliTech Group, Puteaux, France) by the Department of Clinical Pathology, SA
Pathology (Adelaide, SA, Australia) and analysed by an expert haematologist. The
images were captured using an epifluorescence microscopy (model BX51;
Olympus) and camera (UCMAD3/CVM300, Olympus).
Statistical analysis of data. Statistical analysis was carried out in GraphPad
Prism, Version 6.05 (GraphPad, GraphPad Inc., La Jolla, CA, USA). Student’s t-test
was used for statistical significance analysis to determine P-values between each
genotype, unless otherwise stated. Data are expressed as mean± S.E.M. Po0.05
was considered significant.
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